Ethical Compliance
MOREPEN LAB.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
0.1%
Debt
2.2%
Liquidity
4%
Revenue
Debt
Liquidity
0.1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹11.47 |
| Pharmaceutical Products | ₹1,682.13 |
| Other Operting Revenues | ₹8.30 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹2.50 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹2.50 |
| Total: | ₹2.50 |
| Total Revenue: | ₹1,704.40 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹2.50
₹1,704.40
= 0.1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
